Prophylaxis of catheter-related thrombosis in cancer patients
Open Access
- 1 February 2009
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 373 (9663), 523-524
- https://doi.org/10.1016/s0140-6736(09)60178-1
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trialThe Lancet, 2009
- Prevention of Venous ThromboembolismChest, 2008
- Thromboprophylaxis in cancer patients with central venous cathetersThrombosis and Haemostasis, 2008
- Thromboprophylaxis for catheter‐related thrombosis in patients with cancer: a systematic review of the randomized, controlled trialsJournal of Thrombosis and Haemostasis, 2007
- Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With CancerJournal of Clinical Oncology, 2006
- Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trialAnnals of Oncology, 2005
- Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With CancerJournal of Clinical Oncology, 2005
- Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer PatientsJournal of Clinical Oncology, 2005
- Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer PatientsJournal of Clinical Oncology, 2003
- Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous CathetersAnnals of Internal Medicine, 1990